Report Detail
Global Bevacizumab Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
- RnM2806579 |
- 24 January, 2019 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Bevacizumab, sold under the trade name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.
Scope of the Report:
The global Bevacizumab market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bevacizumab.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Bevacizumab market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bevacizumab market by product type and applications/end industries.
Market Segment by Companies, this report covers
Genentech
Amgen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Avastin (bevacizumab)
Mvasi (bevacizumab-awwb)
Market Segment by Applications, can be divided into
Cancer
Eye Diease
Table of Contents
1 Bevacizumab Market Overview
- 1.1 Product Overview and Scope of Bevacizumab
- 1.2 Classification of Bevacizumab by Types
- 1.2.1 Global Bevacizumab Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Bevacizumab Revenue Market Share by Types in 2018
- 1.2.3 Avastin (bevacizumab)
- 1.2.4 Mvasi (bevacizumab-awwb)
- 1.3 Global Bevacizumab Market by Application
- 1.3.1 Global Bevacizumab Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Cancer
- 1.3.3 Eye Diease
- 1.4 Global Bevacizumab Market by Regions
- 1.4.1 Global Bevacizumab Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Bevacizumab Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Bevacizumab Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bevacizumab Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Bevacizumab Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bevacizumab Status and Prospect (2014-2024)
- 1.5 Global Market Size of Bevacizumab (2014-2024)
2 Manufacturers Profiles
- 2.1 Genentech
- 2.1.1 Business Overview
- 2.1.2 Bevacizumab Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Genentech Bevacizumab Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Amgen
- 2.2.1 Business Overview
- 2.2.2 Bevacizumab Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Amgen Bevacizumab Revenue, Gross Margin and Market Share (2017-2018)
3 Global Bevacizumab Market Competition, by Players
- 3.1 Global Bevacizumab Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Bevacizumab Players Market Share
- 3.2.2 Top 10 Bevacizumab Players Market Share
- 3.3 Market Competition Trend
4 Global Bevacizumab Market Size by Regions
- 4.1 Global Bevacizumab Revenue and Market Share by Regions
- 4.2 North America Bevacizumab Revenue and Growth Rate (2014-2019)
- 4.3 Europe Bevacizumab Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Bevacizumab Revenue and Growth Rate (2014-2019)
- 4.5 South America Bevacizumab Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Bevacizumab Revenue and Growth Rate (2014-2019)
5 North America Bevacizumab Revenue by Countries
- 5.1 North America Bevacizumab Revenue by Countries (2014-2019)
- 5.2 USA Bevacizumab Revenue and Growth Rate (2014-2019)
- 5.3 Canada Bevacizumab Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Bevacizumab Revenue and Growth Rate (2014-2019)
6 Europe Bevacizumab Revenue by Countries
- 6.1 Europe Bevacizumab Revenue by Countries (2014-2019)
- 6.2 Germany Bevacizumab Revenue and Growth Rate (2014-2019)
- 6.3 UK Bevacizumab Revenue and Growth Rate (2014-2019)
- 6.4 France Bevacizumab Revenue and Growth Rate (2014-2019)
- 6.5 Russia Bevacizumab Revenue and Growth Rate (2014-2019)
- 6.6 Italy Bevacizumab Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Bevacizumab Revenue by Countries
- 7.1 Asia-Pacific Bevacizumab Revenue by Countries (2014-2019)
- 7.2 China Bevacizumab Revenue and Growth Rate (2014-2019)
- 7.3 Japan Bevacizumab Revenue and Growth Rate (2014-2019)
- 7.4 Korea Bevacizumab Revenue and Growth Rate (2014-2019)
- 7.5 India Bevacizumab Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Bevacizumab Revenue and Growth Rate (2014-2019)
8 South America Bevacizumab Revenue by Countries
- 8.1 South America Bevacizumab Revenue by Countries (2014-2019)
- 8.2 Brazil Bevacizumab Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Bevacizumab Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Bevacizumab Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Bevacizumab by Countries
- 9.1 Middle East and Africa Bevacizumab Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Bevacizumab Revenue and Growth Rate (2014-2019)
- 9.3 UAE Bevacizumab Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Bevacizumab Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Bevacizumab Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Bevacizumab Revenue and Growth Rate (2014-2019)
10 Global Bevacizumab Market Segment by Type
- 10.1 Global Bevacizumab Revenue and Market Share by Type (2014-2019)
- 10.2 Global Bevacizumab Market Forecast by Type (2019-2024)
- 10.3 Avastin (bevacizumab) Revenue Growth Rate (2014-2024)
- 10.4 Mvasi (bevacizumab-awwb) Revenue Growth Rate (2014-2024)
11 Global Bevacizumab Market Segment by Application
- 11.1 Global Bevacizumab Revenue Market Share by Application (2014-2019)
- 11.2 Bevacizumab Market Forecast by Application (2019-2024)
- 11.3 Cancer Revenue Growth (2014-2019)
- 11.4 Eye Diease Revenue Growth (2014-2019)
12 Global Bevacizumab Market Size Forecast (2019-2024)
- 12.1 Global Bevacizumab Market Size Forecast (2019-2024)
- 12.2 Global Bevacizumab Market Forecast by Regions (2019-2024)
- 12.3 North America Bevacizumab Revenue Market Forecast (2019-2024)
- 12.4 Europe Bevacizumab Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Bevacizumab Revenue Market Forecast (2019-2024)
- 12.6 South America Bevacizumab Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Bevacizumab Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Bevacizumab . Industry analysis & Market Report on Bevacizumab is a syndicated market report, published as Global Bevacizumab Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Bevacizumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
